Abstract |
One hundred and twenty-eight patients with iron deficiency anemia were treated with a new intramuscular iron preparation, iron-sorbitol- citric acid. One group of 10 patients received a total of 1000 mg. each of elemental iron intramuscularly. All obtained a rise in hemoglobin of over 2.1 g. %, an elevation of serum iron, and a reticulocyte response over 6%. A second larger group of subjects consisted of 113 prenatal and five gynecologic patients; these received an average total dose of 1050 mg. and 1020 mg., respectively, and the average increase in hemoglobin ranged from 1.6 g. % to 2.5 g. %.None of the patients developed significant side effects after injection or permanent staining at the site of injection. Three patients experienced a transient ache at the injection site, and three developed local urticaria-like reactions lasting 24 hours.This new preparation appears to be a safe and clinically effective therapeutic agent in situations in which parenteral iron is indicated.
|
Authors | D C LEY, S C ROBINSON |
Journal | Canadian Medical Association journal
(Can Med Assoc J)
Vol. 91
Pg. 289-92
(Aug 08 1964)
ISSN: 0008-4409 [Print] Canada |
PMID | 14180535
(Publication Type: Journal Article)
|
Chemical References |
- Citrates
- Drug Combinations
- Ferric Compounds
- Hemoglobins
- citric acid, iron, sorbitol drug combination
- Citric Acid
- Sorbitol
- Iron
|
Topics |
- Anemia
- Anemia, Hypochromic
- Anemia, Iron-Deficiency
- Citrates
- Citric Acid
- Drug Combinations
- Drug Therapy
- Ferric Compounds
- Hemoglobins
- Humans
- Injections, Intramuscular
- Iron
- Sorbitol
- Toxicology
|